Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort descending Project # RFA # PI/Project Leader Institution Title Status
1999 R21 PAR-98-067 VIDAL, MARC MASSACHUSETTS GENERAL HOSPITAL NEW TECHNOLOGIES FOR PROTEIN INTERACTION MAPPING Complete
2007 R21 RFA-CA-07-002 YEE, CASSIAN FRED HUTCHINSON CAN RES CTR IDENTIFICATION OF T CELL-DEFINED ANTIGENS IN OVARIAN CANCER Complete
2010 R21 RFA-CA-09-004 WILLEY, JAMES C. UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS IMPLEMENTATION OF INNOVATIVE RNA SAMPLE QUALITY CONTROL METHODS Complete
2017 R21 RFA-CA-16-001 VAN DAM, ROBERT MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES High-throughput radiochemistry platform for accelerated discovery and development of novel PET imaging agents for cancer Complete
2009 R21 RFA-CA-08-006 BURBULIS, IAN E VTT/MSI MOLECULAR SCIENCES INSTITUTE PCR FOR CARBOHYDRATE CANCER BIOMARKERS Complete
2013 R21 RFA-CA-12-002 PAN, TINGRUI UNIVERSITY OF CALIFORNIA AT DAVIS DIGITAL ONE-DISC-ONE-COMPOUND ARRAY FOR HIGH-THROUGHPUT DISCOVERY OF CANCER-TARGE Complete
2019 R21 RFA-CA-18-004 ANDRES-MARTIN, LAURA NEW YORK STEM CELL FOUNDATION Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections Complete
2000 R21 PAR-99-102 OH, SEAJIN SRI INTERNATIONAL AFM BASED TECHNIQUE--ANALYZES EXPRESSION IN CANCER CELLS Complete
2002 R21 PAR-01-104 KNAPP, DANIEL R. MEDICAL UNIVERSITY OF SOUTH CAROLINA MICROFLUIDIC SYSTEM FOR CANCER PROTEOME ANALYSIS Complete
2005 R21 RFA-CA-05-002 GUDKOV, ANDREI V CLEVELAND CLINIC LERNER COL/MED-CWRU ISSA: NOVEL FUNCTIONAL APPROACH TO CANCER-RELATED GENES Complete
2008 R21 RFA-CA-07-033 LANDEGREN, ULF DAG UPPSALA UNIVERSITY DIAGNOSTIC ANALYSES OF ENDOGENOUS PROTEIN INTERACTIONS Complete
2011 R21 RFA-CA-10-001 HAGEDORN, CURT H. UNIVERSITY OF UTAH SENTINEL POL II RNAS FOR MEASURING RNA INTEGRITY IN BIOSPECIMENS Complete
2015 R21 RFA-CA-14-003 MACCOSS, MICHAEL UNIVERSITY OF WASHINGTON SYSTEMATIC AND COMPREHENSIVE SAMPLING OF PEPTIDES IN MIXTURES BY TANDEM MASS SPECTROMETRY Complete
2018 R21 RFA-CA-17-010 ABBOTT, KAREN L UNIV OF ARKANSAS FOR MED SCIS Novel platform linking cancer-specific glycosylation with cell signaling outcomes Complete
2021 R21 CA20-017 DEININGER, MICHAEL W VERSITI WISCONSIN, INC. A Bioluminescent Assay for Direct Measurement of Sirtuin Activity in Cancer Cells NCE
1999 R21 PAR-98-067 GARNER, HAROLD R UNIVERSITY OF TEXAS SW MED CTR/DALLAS SOFTWARE AND INSTRUMENTATION TO IDENTIFY CANCER GENES Complete
2007 R21 RFA-CA-07-003 ROGERS, RICK HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) SAMPLE PREP METHODS TO ALLOW AUTOMATED 3D ANALYSIS OF MICROVESSEL MORPHOLOGY Complete
2010 R21 RFA-CA-09-004 POPESCU, GABRIEL UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN LABEL FREE IMAGING OF BLOOD SMEARS AND TISSUE BIOPSIES Complete
2017 R21 RFA-CA-16-001 NAEGLE, KRISTEN M WASHINGTON UNIVERSITY A MOLECULAR TOOLKIT FOR THE PRODUCTION OF TYROSINE PHOSPHORYLATED PROTEINS Complete
2017 R21 RFA-CA-16-001 DAVIS, RONALD WAYNE STANFORD UNIVERSITY Nanoneedle microrobots for single cancer cell manipulation and genome editing Complete
2009 R21 RFA-CA-08-006 MESSMER, DAVORKA UNIVERSITY OF CALIFORNIA SAN DIEGO REAL TIME QUANTITATIVE MULTIPLEX ANALYSIS OF CELL-CELL INTERACTIONS Complete
2013 R21 RFA-CA-12-002 ONG, SHAO-EN UNIVERSITY OF WASHINGTON KINASE PROFILING WITH QUANTITITATIVE CHEMOPROTEOMICS Complete
2000 R21 PAR-99-102 BROCK, GRAHAM J UNIVERSITY OF GLASGOW IDENTIFICATION OF M5CPG ALTERATIONS IN BREAST CARCINOMAS Complete
2002 R21 PAR-01-104 HEYDUK, TOMASZ SAINT LOUIS UNIVERSITY MOLECULAR BEACONS FOR PROTEIN DETECTION Complete
2005 R21 RFA-CA-05-002 POOLE, LESLIE B WAKE FOREST UNIVERSITY HEALTH SCIENCES PROFILING OF REDOX-SENSITIVE SIGNALING PROTEINS Complete
2008 R21 RFA-CA-07-033 WANG, TZA-HUEI JOHNS HOPKINS UNIVERSITY NANOBIOSENSING METHOD FOR POINT MUTATION DETECTION OF CANCER Complete
2011 R21 RFA-CA-10-001 GULLEY, MARGARET L UNIV OF NORTH CAROLINA CHAPEL HILL ENHANCED FORMALIN FIXATION TO IMPROVE TESTS ON SOLID TISSUES Complete
2015 R21 RFA-CA-14-003 IAFRATE, ANTHONY JOHN MASSACHUSETTS GENERAL HOSPITAL HIGHLY MULTIPLEXED FISH FOR IN SITU GENOMICS Complete
2018 R21 RFA-CA-17-010 BRENT, ROGER FRED HUTCHINSON CANCER RESEARCH CENTER Precision controllers of mammalian gene expression Complete
2021 R21 CA20-017 SCHULMAN, REBECCA JOHNS HOPKINS UNIVERSITY Secretion responsive Hydrogels for Identification of Functional single T cells (SHIFT) Active
1999 R21 PAR-98-067 BENSIMON, AARON PASTEUR INSTITUTE DETECTION OF GENOMIC ALTERATIONS BY MOLECULAR COMBING Complete
2007 R21 RFA-CA-07-003 BEEBE, DAVID J UNIVERSITY OF WISCONSIN-MADISON MICROFLUIDIC CHANNELS FOR HIGH DENSITY, HIGH PERFORMANCE CULTURE ASSAYS Complete
2010 R21 RFA-CA-09-004 HANSEN, KIRK C UNIVERSITY OF COLORADO DENVER METHODS FOR THE ANALYSIS OF TUMOR EXTRACELLULAR MATRIX Complete
2014 R21 RFA-CA-13-001 TEMPST, PAUL SLOAN-KETTERING INST CAN RESEARCH IMMOBILIZED PROTEASE ACTIVITY TESTS FOR DEVELOPING FUNCTIONAL CANCER BIOMARKERS. Complete
2010 R21 RFA-CA-09-004 TSENG, HSIAN-RONG UNIVERSITY OF CALIFORNIA LOS ANGELES 3D-NANOSTRCUTURED SUBSTRATES FOR DETECTION OF CIRCULATING TUMOR CELLS Complete
2014 R21 RFA-CA-13-001 RIETHMAN, HAROLD WISTAR INSTITUTE A NOVEL SINGLE-MOLECULE TELOMERE CHARACTERIZATION TECHNOLOGY FOR ANALYZING CANCER Complete
2017 R21 RFA-CA-16-001 WONG, WESLEY PHILIP BOSTON CHILDREN'S HOSPITAL Single-molecule mechanical detection of protein and microRNA cancer biomarkers Complete
2009 R21 RFA-CA-08-006 RIEHN, ROBERT NORTH CAROLINA STATE UNIVERSITY RALEIGH EPIGENETIC PROFILING BY NEAR-FIELD UV-RAMAN SCATTERING IN NANOCHANNELS Complete
2013 R21 RFA-CA-12-002 FAN, RONG YALE UNIVERSITY HIGH-THROUGHPUT, MULTIPLEXED DETECTION OF MIRNA BIOMARKERS IN SINGLE CANCER CELLS Complete
2020 R21 RFA-CA-19-019 HUR, SOOJUNG CLAIRE JOHNS HOPKINS UNIVERSITY Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy Complete
2000 R21 PAR-99-102 SMITH, RICHARD D BATTELLE PACIFIC NORTHWEST LABORATORIES HIGH THROUGHPUT FTICR FOR MOLECULAR ANALYSIS OF CANCER Complete
2002 R21 PAR-01-104 SOMMER, STEVE SEEV CITY OF HOPE/BECKMAN RESEARCH INSTITUTE PAP: A TECHNOLOGY PLATFORM Complete
2005 R21 RFA-CA-05-002 FRANK-KAMENETSKII, MAXIM D BOSTON UNIVERSITY FLUORESCENCE IN SITU DETECTION OF SHORT DNA SEQUENCES Complete
2008 R21 RFA-CA-07-033 KOIDE, SHOHEI UNIVERSITY OF CHICAGO HIGH-PERFORMANCE AFFINITY REAGENTS FOR PEPTIDE EPITOPES Complete
2011 R21 RFA-CA-10-001 HRUDKA, BRIAN BIOSPECIMEN PROCUREMENT SOLUTIONS, INC. DEVELOPMENT OF A SYSTEM (DEVICES AND PROTOCOLS) TO IMPROVE BIOSPECIMEN PRESERVATI Complete
2015 R21 RFA-CA-14-003 DRAKE, RICHARD R. MEDICAL UNIVERSITY OF SOUTH CAROLINA DIRECT TUMOR GLYCAN PROFILING ON TISSUE MICROARRAYS Complete
2018 R21 RFA-CA-17-010 ENGLER, ADAM JEFFREY UNIVERSITY OF CALIFORNIA, SAN DIEGO Developing Adhesome Technology as a Physical Marker of Highly Metastatic Cells Complete
2022 R21 CA21-003 SNYDER, JOSHUA CLAIR DUKE UNIVERSITY Mouse Paint: A massively combinatorial approach for illuminating tumor heterogeneity in True Color Active
1999 R21 PAR-98-067 WANG, YUE CATHOLIC UNIVERSITY OF AMERICA INTELLIGENT MAPPING OF GENE EXPRESSION PROFILES Complete
2007 R21 RFA-CA-07-003 MUNN, LANCE L MASSACHUSETTS GENERAL HOSP MICROFLUIDIC DEVICE FOR ISOLATING RARE BLOOD CELLS Complete

Pages